7th Annual Clinical Research in Emerging Countries
14th August 2012 — 16th August 2012

Optimizing Clinical Research within Emerging Countries by Overcoming Operational and Regulatory Challenges to Ensure Trial Success

Key conference topics

• Develop a robust global clinical research strategy to ensure trial compliance with Eli Lilly
• Overcome significant operational challenges while conducting clinical research in emerging markets with Johnson & Johnson
• Explore the global and regional regulatory requirements in emerging countries with Merck
• Overcome common cultural barriers to optimize trial success with Forest Research
• Gain insight on better clinical data management

Key conference features

• Two Pre-Conference Workshops on August 14, 2012
• Pre-Conference Workshop A: Improving Global Clinical Strategies and Evaluating Key Criteria for Optimum Site Selection in Emerging Countries led by Talat Ashraf, MD, MS, Senior Medical Director, Medtronic
• Pre-Conference Workshop B: Evaluating the Unique Operational and Regulatory Challenges as well as Barriers to Entry within the Middle East, South Africa and Turkey led by Pol Vandenbroucke, Vice President, Development, Emerging Markets & Established Products, Pfizer

Conference focus
Western pharmaceutical companies are facing huge challenges with patent expirations, a tougher regulatory environment, downward pricing pressure and diminishing returns to R&D. The concept of conducting clinical research in emerging markets is increasingly becoming more attractive to global clinical researchers for optimizing their commercial success. From a largely untapped and diverse patient population to less costly trial conduct, the emerging  markets offer much promise in this increasingly competitive industry for international drug developers.

The marcus evans 7th Annual Clinical Research in Emerging Countries Conference will focus on the regulatory framework in the different emerging markets, analyze the challenges faced in the different regions, understand the ethical issues, including issues with consent, and enable executives conducting clinical trials in these unique markets to design and conduct effective and compliant clinical research. Attendees will be able to leverage emerging countries as a platform to enhance global clinical development through analyzing the complex and unique conditions of conducting clinical trials in emerging markets.

By attending this event, those involved in the Pharmaceutical, Biopharma, and Medical Device industries will be able to develop a global strategy for conducting clinical research in emerging markets to ensure trial success.

Attending This Conference Will Enable You To:
1. Address unique regulatory challenges within emerging markets
2. Analyze the conditions for conducting safe and effective clinical trials
3. Overcome operational issues in conducting clinical research
4. Address current recruitment and retention challenges
5. Explore different therapeutic areas for global trials
Industry leaders attending this conference will benefit from a dynamic presentation format consisting of workshops, panel discussions and case studies. Attendees will experience highly interactive conference sessions, 10-15 minutes of Q&A time after each presentation, 4+ hours of networking, and exclusive online access to materials post-event.

Past Attendees:
Senior level executives from leading pharmaceutical and medical device organizations with responsibilities or involvement in the following areas:

· Clinical Research
· Clinical Development
· Clinical Operations
· Regulatory Affairs
· Site Director
· Study Director
· Medical Director
· Medical Affairs
· Global Clinical Affairs/Regional Clinical Affairs

Expected Number of Attendees

NA

View Conference Website: 7th Annual Clinical Research in Emerging Countries

Price of Attendance

n/a

Brochure

View Event Brochure

Location

Philadelphia
Philadelphia
Philadelphia
United States
Philadelphia